Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Biologics for severe asthma have known side effects, but some new risks need more study.

Tocilizumab might be an effective treatment for COVID-19.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Talquetamab may cause hair loss and skin issues.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Dupilumab can cause psoriasis in some patients.

Baricitinib improved hair loss and arthritis in a lupus patient.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Bortezomib chemotherapy can cause temporary skin rashes.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.